Literature DB >> 6926810

Mixed connective tissue disease: some statements.

D Alarcón-Segovia.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6926810     DOI： 10.1007/bf02275596

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Mixed connective tissue disease. Appearance of antibodies to ribonucleoprotein following corticosteroid treatment.

Authors:  D Alarcon-Segovia
Journal:  J Rheumatol       Date:  1979 Nov-Dec       Impact factor: 4.666

2.  Mixed connective tissue disease - a decade of growing pains.

Authors:  D Alarcon-Segovia
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

3.  Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.

Authors:  E Fishbein; F Ramos-Niembro; D Alarcon-Segovia
Journal:  J Rheumatol       Date:  1978       Impact factor: 4.666

4.  Human post-thymic precursor cells in health and disease. IX. Immunoregulatory T cell circuits in peripheral blood of patients with rheumatoid arthritis.

Authors:  R Palacios; A Ruíz-Arguelles; D Alarcón-Segovia
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

5.  Human postthymic precursor cells in health and disease. II. Their loss and dysfunction in systemic lupus erythematosus and their partial correction with serum thymic factor.

Authors:  R Palacios; D Alarcón-Segovia; L Llorente; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  J Clin Lab Immunol       Date:  1981-03

6.  Mixed connective tissue disease - a subset with sequential clinical and laboratory features.

Authors:  K D Grant; L E Adams; E V Hess
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

7.  Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.

Authors:  T Mimori; M Akizuki; H Yamagata; S Inada; S Yoshida; M Homma
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

8.  Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.

Authors:  D Alarcón-Segovia; R Palacios; G Ibáñez de Kasep
Journal:  J Clin Lab Immunol       Date:  1981-05

9.  Human postthymic precursor cells in health and disease. IV. Abnormalities in immunoregulatory T cell circuits in mixed connective tissue disease.

Authors:  D Alarcón-Segovia; R Palacios
Journal:  Arthritis Rheum       Date:  1981-12
  9 in total
  3 in total

1.  Evaluation of lymphocyte activation in skin lesions of patients with mixed connective tissue disease and discoid lupus erythematodes.

Authors:  V Bergroth; Y T Konttinen; H Piirainen; E Johansson; D Nordström; M Malmström
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  P Ruuska; R Hämeenkorpi; S Forsberg; H Julkunen; R Mäkitalo; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

3.  Datasets of YY1 expression in rheumatoid arthritis patients.

Authors:  Jinpiao Lin; Yujue He; Junmin Chen; Zhiyong Zeng; Qishui Ou
Journal:  Data Brief       Date:  2016-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.